Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (vol 12, 7217, 2021): Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (Nature Communications, (2021), 12, 1, (7217), 10.1038/s41467-021-27410-5)

Gayatri Amirthalingam*, Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, Elise Tessier, Sathyavani Subbarao, Georgina Ireland, Frances Baawuah, Ezra Linley, Lenesha Warrener, Michelle O’Brien, Corinne Whillock, Paul Moss, Shamez N. Ladhani, Kevin E. Brown, Mary E. Ramsay

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The original version of this Article contained an error in Fig. 4, in which the titles for each section were incorrectly shifted to the left rather than being placed above the corresponding section of the figure. This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish
Article number733
Number of pages1
JournalNature Communications
Volume13
Issue number1
DOIs
Publication statusPublished - 2 Feb 2022

Bibliographical note

Publisher Copyright:
© 2022, Crown.

Fingerprint

Dive into the research topics of 'Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (vol 12, 7217, 2021): Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (Nature Communications, (2021), 12, 1, (7217), 10.1038/s41467-021-27410-5)'. Together they form a unique fingerprint.

Cite this